Cargando...
Effects of Risperidone and Galantamine treatment on Alzheimer biomarker levels in cerebrospinal fluid
BACKGROUND: Treatment for neuropsychiatric symptoms (NPS) in dementia is insufficient. Antipsychotics and acetylcholinesterase inhibitors are used generating symptomatic improvements in behaviour and cognition, but few studies have investigated their effect on Alzheimer biomarkers in cerebrospinal f...
Guardado en:
| Publicado en: | J Alzheimers Dis |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6203339/ https://ncbi.nlm.nih.gov/pubmed/28269767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-160758 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|